Insuman Rapid

Insulin Human, the active ingredient in Insuman Rapid, is an insulin presented as a solution for injection for subcutaneous use. It is used to control blood glucose in patients with type 1 and type 2 diabetes mellitus. By mimicking natural insulin, it helps regulate glucose metabolism.

GNH USA supplies Insuman Rapid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable cold‑chain logistics for injectable products across multiple continents.

Insuman Rapid, a rapid‑acting insulin, is used to manage hyperglycemia in diabetes.

- Type 1 diabetes mellitus: provides rapid glucose lowering to cover meals and correct hyperglycemia. - Type 2 diabetes mellitus: assists in post‑prandial glucose control when oral agents are insufficient. - Hospitalized patients with diabetes: enables precise insulin dosing for acute glycemic management.

Insuman Rapid may cause a range of adverse reactions.

Common Side Effects: - Hypoglycemia: low blood sugar episodes, especially if meals are missed. - Injection site reactions: redness, swelling, or itching at the injection site. - Weight gain: modest increase due to improved glucose utilization. - Lipodystrophy: localized fat tissue changes with repeated injections. - Edema: mild fluid retention. - Headache: transient discomfort.

Serious or Rare Side Effects: - Severe hypoglycemia: neurological impairment requiring immediate treatment. - Anaphylactic reaction: life‑threatening allergy to insulin or excipients. - Insulin allergy: systemic rash, urticaria, or angioedema. - Hypokalemia: low potassium levels during rapid glucose shifts. - Acute allergic edema: rapid swelling of tissues. - Serum insulin antibodies: may alter insulin action.

When using Insuman Rapid, consider the following precautions.

- Blood glucose monitoring: check levels frequently to avoid hypoglycemia. - Dose adjustments during illness: reduce or increase insulin based on carbohydrate intake and stress. - Renal impairment: use cautiously as reduced clearance may increase hypoglycemia risk. - Hypoglycemia unawareness: patients with impaired warning signs need close supervision. - Pregnancy and lactation: evaluate risk‑benefit ratio; insulin is generally preferred but consult a specialist. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake the vial.

Insuman Rapid can interact with several medications.

Major Interactions (Avoid): - Beta‑blockers: may mask hypoglycemia symptoms, requiring careful monitoring. - Alcohol: can potentiate insulin’s glucose‑lowering effect, increasing hypoglycemia risk.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may raise blood glucose, necessitating dose adjustments. - Corticosteroids: can increase insulin resistance, requiring higher insulin doses. - Oral contraceptives: may affect insulin sensitivity, warranting closer glucose monitoring. - ACE inhibitors: may enhance insulin’s effect on potassium levels, monitor electrolytes.